Yes, HCV. Thank you. Was I detecting a sense of genuine optimism in the Q&A? It didn't last long, but it seemed to me that JP was certainly conveying a sense that IDIX was up to the fight for a front line HCV treatment? I think the potency factor somehow connoted a high degree of anticipation regarding the safety screening and dosing. All above from an extremely naive listener.
Market Data 
Markets 
AI
